CME Networks - http://www.cmenetworks.com
Bipolar Disorder CME: MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder: The France Foundation: Minneapolis, MN: October 2, 2008
http://www.cmenetworks.com/cme/9842/1/Bipolar-Disorder-CME-MEASURE---From-Neurobiology-to-Pharmacotherapy-Advances-in-Our-Understanding-of-Bipolar-Disorder-The-France-Foundation-Minneapolis-MN-October-2-2008/Page1.html
MEASURE by The France Foundation

Now in it's sixth year, the objective of MEASURE is to provide psychiatrists and health care providers with a comprehensive continuing medical education program that will examine emerging clinical advances while addressing educational issues critical to improving the management of serious psychiatric disorders, including bipolar disorder.  
By MEASURE by The France Foundation
Published on 09/12/2008
 
MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder

The France Foundation

October 2, 2008

The goal of the MEASURE Dinner Meetings is to provide psychiatrists with an interactive continuing medical education activity that addresses ongoing complex issues with the diagnosis and treatment of patients with bipolar disorder. Expert bipolar faculty deliver a lecture entitled "From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder" followed by a question/answer session.


MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder
CME Sponsor: The France Foundation

Location:
McCormick & Schmick's Seafood Restaurant
Minneapolis, MN


Course Directors/Instructors:
David E. Adson, MD

Course Fee:
Free


Number of Credits:
1 AMA PRA Category 1

Link

Detailed Description:

The goal of the MEASURE Dinner Meetings is to provide psychiatrists with an interactive continuing medical education activity that addresses ongoing complex issues with the diagnosis and treatment of patients with bipolar disorder. Expert bipolar faculty deliver a lecture entitled "From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder" followed by a question/answer session.

For More Information
Call Toll Free: 1-866-856-1998  Fax: 1-860-434-5390


Learning Objectives:
  • Describe neurophysiological findings and neurocognitive deficits in bipolar disorder and various phases of the illness
  • Discuss how individual factors such as age, the presence of comorbidities, or ethnic/cultural issues impact the diagnosis and treatment of bipolar disorder
  • Interpret emerging data from studies on bipolar disorder therapy
  • Determine the appropriate strategies for multimodal combination therapies in the acute and long-term management of bipolar disorder